- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05723861
Virtual Reality During Colonoscopy
Study Overview
Detailed Description
This project aims to investigate the clinical effectiveness and implementation potential of using VR during colonoscopy using a hybrid type 1 effectiveness-implementation design through 2 work packages. The first work package will investigate the effect of VR on pain, anxiety, patients' comfort, and satisfaction during colonoscopy using a multicenter parallel randomized controlled, open-label trial. It will also be a qualitative interview to explore the healthcare professionals' and patients' experiences with using VR during colonoscopy.
The second work package will evaluate the implementation process using mix method to understand why the intervention is (or is not) more effective than usual care, whether high intervention fidelity is achieved, what barriers and facilitators there are, how these may translate into real-world implementation, and what modifications can be made to maximize implementation success. This will be achieved using quantitative and qualitative approaches with a focus on the process evaluation around the RE-AIM framework (Reach, Effectiveness, Adoption, Implementation, and Maintenance). Quantitative (e.g., quantitative analysis of patient participation rate and reasons for refusal assessment or ineligibility) and qualitative (e.g., qualitative interview of facilitators/barriers to implementing VR) data analyses will be combined to conclude the reach, adoption, implementation, and maintenance of the intervention.
The specific aims of the project will be pursued through 2 work packages and include:
Intervention effectiveness work package Study I: To investigate the effect of VR on pain, anxiety, patients' comfort, and satisfaction during colonoscopy.
Study II: To explore the healthcare professionals' and patients' experiences with using VR during colonoscopy.
Implementation work package
Qualitative part:
- To explore facilitators/barriers to adoption and implementing using VR during colonoscopy.
- To explore the facilitators/barriers to sustaining using VR during colonoscopy after the study was completed.
Quantitative part:
1) To examine the potential of using VR under colonoscopy for reach and adoption.
Participants will be recruited from adult patients referred to the two outpatient Endoscopy Units. Patients who meet the inclusion criteria and give written consent will be consecutively enrolled in the trial. These patients will be randomly allocated to an experimental group (using VR), or a control group (routine care). Outcomes will be measured immediately before, after, and/or during the procedure.
Some patients in the intervention group and healthcare professionals will be asked to participate in a qualitative interview to share their experiences of using VR under colonoscopy and to evaluate the implementation process.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Copenhagen, Denmark, 2730
- Department of Gastroenterology, Herlev and Gentofte Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- age ≥ 18
- any elective indication of colonoscopy
Exclusion Criteria:
- having visual impairments,
- having dementia
- limited Danish language skills
- a high tendency to travel sickness
- having skin disease in the facial area
- having epilepsy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: VR group
Participants will receive Virtual Reality intervention in addition to routine care during colonoscopy.
|
We will use the Pico Headset, a three-dimensional Gear with a connected tablet, and will be positioned on the head with elastic straps.
Patients will be instructed about the VR device before their procedure and virtual experiences will initiate just before colonoscope insertion and continuously delivered throughout the procedure for max of 20 minutes.
Patients will experience max of 20 minutes of VR and if colonoscopy lasts longer than 20 min, the remaining time of colonoscopy will be performed without using VR.
The visualized content of VR will be chosen by the participants among three available contents including beach, nature, or mountain with relaxing music.
Participants could opt out and/or request standard medications for pain at any time before or during the procedure.
|
No Intervention: Control group
Receive routine treatment.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Patient pain before colonoscopy procedure
Time Frame: 5 - 15 minutes before starting colonoscopy.
|
Patients will rate their pain using an 11-point numeric rating scale (NRS) ranging from 0 (no pain) to 10 (highest imaginable pain).
|
5 - 15 minutes before starting colonoscopy.
|
Patient pain during colonoscopy procedure
Time Frame: During the colonoscopy procedure (from the time colonoscopy is started until ended).
|
Patients will rate their pain using an 11-point numeric rating scale (NRS) ranging from 0 (no pain) to 10 (highest imaginable pain).
|
During the colonoscopy procedure (from the time colonoscopy is started until ended).
|
Patient pain after colonoscopy procedure
Time Frame: 5 - 15 minutes after the colonoscopy is ended.
|
Patients will rate their pain using an 11-point numeric rating scale (NRS) ranging from 0 (no pain) to 10 (highest imaginable pain).
|
5 - 15 minutes after the colonoscopy is ended.
|
Patient anxiety before colonoscopy procedure
Time Frame: 5 - 15 minutes before starting colonoscopy.
|
Patient anxiety will be measured by the short form of the State Trait Anxiety Inventory (STAI) which has five items with a 4-point Likert-type scale ranging from 0 to 3.
|
5 - 15 minutes before starting colonoscopy.
|
Patient anxiety after colonoscopy procedure
Time Frame: 5 - 15 minutes after the colonoscopy is ended.
|
Patient anxiety will be measured by the short form of the State Trait Anxiety Inventory (STAI) which has five items with a 4-point Likert-type scale ranging from 0 to 3.
|
5 - 15 minutes after the colonoscopy is ended.
|
Patient comfort during colonoscopy procedure
Time Frame: During the colonoscopy procedure (from the time colonoscopy is started until ended).
|
Patient comfort will be measured by a nurse/researcher using the five-point Modified.
Gloucester Comfort Scale (MGCS) ranging from 1 (no discomfort) to 5 (severe discomfort).
|
During the colonoscopy procedure (from the time colonoscopy is started until ended).
|
Patient comfort after colonoscopy procedure
Time Frame: 5 - 15 minutes after the colonoscopy is ended.
|
Patient comfort will be measured by a nurse/researcher using the five-point Modified.
Gloucester Comfort Scale (MGCS) ranging from 1 (no discomfort) to 5 (severe discomfort).
|
5 - 15 minutes after the colonoscopy is ended.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Patient satisfaction
Time Frame: 5 - 15 minutes after the colonoscopy is ended.
|
Patient satisfaction with the procedure will be measured using an 11-point numeric rating scale ranging from 0 (no satisfaction at all) to 10 (definitely satisfied).
|
5 - 15 minutes after the colonoscopy is ended.
|
Patient / healthcare professional experience with using VR during colonoscopy
Time Frame: 30 minutes - one week after the procedure
|
Qualitative interview of some patients in the intervention group and and healthcare professionals.
|
30 minutes - one week after the procedure
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Mahdi Shamali, PhD, Herlev and Gentofte University Hospital
- Principal Investigator: Hanne Konradsen, PhD, Herlev and Gentofte University Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- VR2023
- E 19215 09 (Other Identifier: Herlev Hospital)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Colonoscopy
-
Borland-Groover ClinicValley Medical Products, LLC is paying for the study and is the sponsor....CompletedColonoscopy | Screening Colonoscopy | Surveillance ColonoscopyUnited States
-
Josue AliagaCompleted
-
Endostart srlCompleted
-
Hospital Central Norte PEMEXCompletedPerformance of Colonoscopy | Tolerance of ColonoscopyMexico
-
VA Office of Research and DevelopmentVA Palo Alto Health Care System; VA Northern California Health Care SystemCompletedWater Exchange Colonoscopy | Unsedated Colonoscopy | Cap | Colonoscopy PainUnited States
-
Rambam Health Care CampusUnknownInadequate Preparation for Colonoscopy; Personalized Colonoscopy PreparationIsrael
-
Dalin Tzu Chi General HospitalCompletedColonoscopy | Intubation Time | Cap-assisted ColonoscopyTaiwan
-
Valduce HospitalCompletedUnsedated Colonoscopy | Warm Water | CO2 ColonoscopyItaly
-
Kartal Kosuyolu Yuksek Ihtisas Education and Research...UnknownColonoscopy | Complete Colonoscopy | Cecum Intubation Time | İleum Intubation TimeTurkey
-
Daewoong Pharmaceutical Co. LTD.Not yet recruiting
Clinical Trials on VR
-
National Institute of General Medical Sciences...Completed
-
Shanghai Mental Health CenterNanjing XR-Oasis Technology Co., Ltd.RecruitingBipolar Disorder | Interventional Study | VRChina
-
Catholic University of the Sacred HeartFondazione PoliambulanzaRecruiting
-
Indiana UniversityAmerican Heart AssociationCompletedHeart Failure | Cognitive DysfunctionUnited States
-
Children's Hospital Medical Center, CincinnatiCompleted
-
University of Maryland, BaltimoreRecruitingPain | Virtual Reality | Temporomandibular Disorder | PlaceboUnited States
-
Cornell UniversityRecruitingPain ThresholdUnited States
-
Floreo, Inc.RecruitingAutism Spectrum Disorder | Social CommunicationUnited States
-
University of California, DavisNational Institute of Mental Health (NIMH)Recruiting
-
National Institutes of Health Clinical Center (CC)RecruitingNeoplasm | CaregiversUnited States